Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells

Salvatore Lecca, Miriam Melis, Antonio Luchicchi, Maria Grazia Ennas, Maria Paola Castelli, Anna Lisa Muntoni, Marco Pistis

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Recent findings have underlined the rostromedial tegmental nucleus (RMTg), a structure located caudally to the ventral tegmental area, as an important site involved in the mechanisms of aversion. RMTg contains γ-aminobutyric acid neurons responding to noxious stimuli, densely innervated by the lateral habenula and providing a major inhibitory projection to reward-encoding midbrain dopamine (DA) neurons. One of the key features of drug addiction is the perseverance of drug seeking in spite of negative and unpleasant consequences, likely mediated by response suppression within neural pathways mediating aversion. To investigate whether the RMTg has a function in the mechanisms of addicting drugs, we studied acute effects of morphine, cocaine, the cannabinoid agonist WIN55212-2 (WIN), and nicotine on putative RMTg neurons. We utilized single unit extracellular recordings in anesthetized rats and whole-cell patch-clamp recordings in brain slices to identify and characterize putative RMTg neurons and their responses to drugs of abuse. Morphine and WIN inhibited both firing rate in vivo and excitatory postsynaptic currents (EPSCs) evoked by stimulation of rostral afferents in vitro, whereas cocaine inhibited discharge activity without affecting EPSC amplitude. Conversely, nicotine robustly excited putative RMTg neurons and enhanced EPSCs, an effect mediated by α7-containing nicotinic acetylcholine receptors. Our results suggest that activity of RMTg neurons is profoundly influenced by drugs of abuse and, as important inhibitory afferents to midbrain DA neurons, they might take place in the complex interplay between the neural circuits mediating aversion and reward.

Original languageEnglish
Pages (from-to)589-602
Number of pages14
JournalNeuropsychopharmacology
Volume36
Issue number3
DOIs
Publication statusPublished - Feb 2011
Externally publishedYes

Cite this

Lecca, Salvatore ; Melis, Miriam ; Luchicchi, Antonio ; Ennas, Maria Grazia ; Castelli, Maria Paola ; Muntoni, Anna Lisa ; Pistis, Marco. / Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. In: Neuropsychopharmacology. 2011 ; Vol. 36, No. 3. pp. 589-602.
@article{75cf982e66ee47c1918ca13e7584c0db,
title = "Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells",
abstract = "Recent findings have underlined the rostromedial tegmental nucleus (RMTg), a structure located caudally to the ventral tegmental area, as an important site involved in the mechanisms of aversion. RMTg contains γ-aminobutyric acid neurons responding to noxious stimuli, densely innervated by the lateral habenula and providing a major inhibitory projection to reward-encoding midbrain dopamine (DA) neurons. One of the key features of drug addiction is the perseverance of drug seeking in spite of negative and unpleasant consequences, likely mediated by response suppression within neural pathways mediating aversion. To investigate whether the RMTg has a function in the mechanisms of addicting drugs, we studied acute effects of morphine, cocaine, the cannabinoid agonist WIN55212-2 (WIN), and nicotine on putative RMTg neurons. We utilized single unit extracellular recordings in anesthetized rats and whole-cell patch-clamp recordings in brain slices to identify and characterize putative RMTg neurons and their responses to drugs of abuse. Morphine and WIN inhibited both firing rate in vivo and excitatory postsynaptic currents (EPSCs) evoked by stimulation of rostral afferents in vitro, whereas cocaine inhibited discharge activity without affecting EPSC amplitude. Conversely, nicotine robustly excited putative RMTg neurons and enhanced EPSCs, an effect mediated by α7-containing nicotinic acetylcholine receptors. Our results suggest that activity of RMTg neurons is profoundly influenced by drugs of abuse and, as important inhibitory afferents to midbrain DA neurons, they might take place in the complex interplay between the neural circuits mediating aversion and reward.",
keywords = "Action Potentials, Animals, Animals, Newborn, Behavior, Animal, Benzoxazines, Cocaine, Dopamine, Drug Interactions, Electric Stimulation, Excitatory Postsynaptic Potentials, Gene Expression Regulation, In Vitro Techniques, Male, Mecamylamine, Morphine, Morpholines, Naloxone, Naphthalenes, Narcotic Antagonists, Neural Inhibition, Neural Pathways, Neurons, Nicotinic Antagonists, Patch-Clamp Techniques, Piperidines, Pyrazoles, Rats, Rats, Sprague-Dawley, Street Drugs, Time Factors, Ventral Tegmental Area, Journal Article, Research Support, Non-U.S. Gov't",
author = "Salvatore Lecca and Miriam Melis and Antonio Luchicchi and Ennas, {Maria Grazia} and Castelli, {Maria Paola} and Muntoni, {Anna Lisa} and Marco Pistis",
year = "2011",
month = "2",
doi = "10.1038/npp.2010.190",
language = "English",
volume = "36",
pages = "589--602",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "3",

}

Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. / Lecca, Salvatore; Melis, Miriam; Luchicchi, Antonio; Ennas, Maria Grazia; Castelli, Maria Paola; Muntoni, Anna Lisa; Pistis, Marco.

In: Neuropsychopharmacology, Vol. 36, No. 3, 02.2011, p. 589-602.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells

AU - Lecca, Salvatore

AU - Melis, Miriam

AU - Luchicchi, Antonio

AU - Ennas, Maria Grazia

AU - Castelli, Maria Paola

AU - Muntoni, Anna Lisa

AU - Pistis, Marco

PY - 2011/2

Y1 - 2011/2

N2 - Recent findings have underlined the rostromedial tegmental nucleus (RMTg), a structure located caudally to the ventral tegmental area, as an important site involved in the mechanisms of aversion. RMTg contains γ-aminobutyric acid neurons responding to noxious stimuli, densely innervated by the lateral habenula and providing a major inhibitory projection to reward-encoding midbrain dopamine (DA) neurons. One of the key features of drug addiction is the perseverance of drug seeking in spite of negative and unpleasant consequences, likely mediated by response suppression within neural pathways mediating aversion. To investigate whether the RMTg has a function in the mechanisms of addicting drugs, we studied acute effects of morphine, cocaine, the cannabinoid agonist WIN55212-2 (WIN), and nicotine on putative RMTg neurons. We utilized single unit extracellular recordings in anesthetized rats and whole-cell patch-clamp recordings in brain slices to identify and characterize putative RMTg neurons and their responses to drugs of abuse. Morphine and WIN inhibited both firing rate in vivo and excitatory postsynaptic currents (EPSCs) evoked by stimulation of rostral afferents in vitro, whereas cocaine inhibited discharge activity without affecting EPSC amplitude. Conversely, nicotine robustly excited putative RMTg neurons and enhanced EPSCs, an effect mediated by α7-containing nicotinic acetylcholine receptors. Our results suggest that activity of RMTg neurons is profoundly influenced by drugs of abuse and, as important inhibitory afferents to midbrain DA neurons, they might take place in the complex interplay between the neural circuits mediating aversion and reward.

AB - Recent findings have underlined the rostromedial tegmental nucleus (RMTg), a structure located caudally to the ventral tegmental area, as an important site involved in the mechanisms of aversion. RMTg contains γ-aminobutyric acid neurons responding to noxious stimuli, densely innervated by the lateral habenula and providing a major inhibitory projection to reward-encoding midbrain dopamine (DA) neurons. One of the key features of drug addiction is the perseverance of drug seeking in spite of negative and unpleasant consequences, likely mediated by response suppression within neural pathways mediating aversion. To investigate whether the RMTg has a function in the mechanisms of addicting drugs, we studied acute effects of morphine, cocaine, the cannabinoid agonist WIN55212-2 (WIN), and nicotine on putative RMTg neurons. We utilized single unit extracellular recordings in anesthetized rats and whole-cell patch-clamp recordings in brain slices to identify and characterize putative RMTg neurons and their responses to drugs of abuse. Morphine and WIN inhibited both firing rate in vivo and excitatory postsynaptic currents (EPSCs) evoked by stimulation of rostral afferents in vitro, whereas cocaine inhibited discharge activity without affecting EPSC amplitude. Conversely, nicotine robustly excited putative RMTg neurons and enhanced EPSCs, an effect mediated by α7-containing nicotinic acetylcholine receptors. Our results suggest that activity of RMTg neurons is profoundly influenced by drugs of abuse and, as important inhibitory afferents to midbrain DA neurons, they might take place in the complex interplay between the neural circuits mediating aversion and reward.

KW - Action Potentials

KW - Animals

KW - Animals, Newborn

KW - Behavior, Animal

KW - Benzoxazines

KW - Cocaine

KW - Dopamine

KW - Drug Interactions

KW - Electric Stimulation

KW - Excitatory Postsynaptic Potentials

KW - Gene Expression Regulation

KW - In Vitro Techniques

KW - Male

KW - Mecamylamine

KW - Morphine

KW - Morpholines

KW - Naloxone

KW - Naphthalenes

KW - Narcotic Antagonists

KW - Neural Inhibition

KW - Neural Pathways

KW - Neurons

KW - Nicotinic Antagonists

KW - Patch-Clamp Techniques

KW - Piperidines

KW - Pyrazoles

KW - Rats

KW - Rats, Sprague-Dawley

KW - Street Drugs

KW - Time Factors

KW - Ventral Tegmental Area

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1038/npp.2010.190

DO - 10.1038/npp.2010.190

M3 - Article

VL - 36

SP - 589

EP - 602

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 3

ER -